Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats
M. Kovacs et Av. Schally, Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats, P NAS US, 98(21), 2001, pp. 12197-12202
Citations number
41
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
The mechanisms through which luteinizing hormone (LH)-releasing hormone (LH
RH) antagonists suppress pituitary gonadotroph functions and LHRH-receptor
expression are incompletely understood. Consequently, we investigated the d
irect effect of LHRH antagonist cetrorelix in vitro on the expression of th
e pituitary LHRH-R gene and its ability to counteract the exogenous LHRH an
d the agonist triptorelin in the regulation of this gene. We also compared
the effects of chronic administration of cetrorelix and triptorelin on the
LHRH-R mRNA level and gonadotropin secretion in ovariectomized (OVX) and no
rmal female rats. The exposure of pituitary cells in vitro to 3-min pulses
of 1 nM LHRH or 0.1 nM triptorelin for 5 h increased the LHRH-R mRNA level
by 77-88%. Continuous perfusion of the cells with 50 nM cetrorelix did not
cause any significant changes, but prevented the stimulatory effect of LHRH
pulses on the receptor mRNA expression. In OVX rats, 10 days after adminis
tration of a depot formulation of cetrorelix, releasing 100 mug of peptide
daily, the elevated LHRH-R mRNA level was decreased by 73%, whereas daily i
njection of 100 mug of triptorelin caused a 41% suppression. In normal fema
le rats, cetrorelix treatment suppressed the LHRH-R mRNA level by 33%, but
triptorelin increased it by 150%. The highly elevated serum LH levels in OV
X rats and the normal LH concentration of cycling rats were rapidly and com
pletely suppressed by cetrorelix. Triptorelin decreased the serum LH in OVX
rats to the precastration level, but had no effect on basal LH in normal r
ats. Our results confirm that LHRH antagonists, such as cetrorelix, inhibit
the gene expression of pituitary LHRH-R indirectly, by counteracting the s
timulatory effect of LHRH. A rapid suppression of serum LH by LHRH antagoni
sts would be advantageous in the treatment of sex hormone-dependent tumors
and other conditions.